Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
Public ClinicalTrials.gov record NCT01700946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
Study identification
- NCT ID
- NCT01700946
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- CliniMACS Device
- aldesleukin Biological
- allogeneic hematopoietic stem cell transplantation Procedure
- clofarabine Drug
- cyclophosphamide Drug
- cytarabine Drug
- dexamethasone Drug
- etoposide Drug
- laboratory biomarker analysis Other
- mercaptopurine Drug
- methotrexate Drug
- mitoxantrone Drug
- natural killer cell infusion Biological
- pegaspargase Drug
- rituximab Biological
- teniposide Drug
- therapeutic hydrocortisone Drug
- vinblastine Drug
- vincristine sulfate Drug
Device · Biological · Procedure + 2 more
Eligibility (public fields only)
- Age range
- Up to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 14, 2013
- Primary completion
- Jul 23, 2021
- Completion
- Jul 23, 2021
- Last update posted
- Sep 27, 2022
2013 – 2021
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rady Children's Hospital and Health Center | San Diego | California | 92123 | — |
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01700946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2022 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01700946 live on ClinicalTrials.gov.